abstract |
Provided is an IgE peptide vaccine which can be used in the prevention or treatment of allergic disorders affecting animals other than mice, such as humans and dogs. A peptide comprising (i) an amino acid sequence represented by SEQ. ID No. 28, or (ii) an amino acid sequence containing at least ten continuous amino acids among the amino acid sequence represented by SEQ. ID No. 28, wherein, when the peptide has been administered to an animal, the peptide specifically binds with the CH3 region of IgE antibodies of the animal, preventing the IgE antibodies from binding with IgE receptors. |